Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype

被引：0
|
作者：
Peiwei Zhao
Juan Huang
Huicong Fu
Jiali Xu
Tianhong Li
Xiankai Zhang
Qingjie Meng
Lei Zhang
Li Tan
Wen Zhang
Hebin Chen
Xiaoxia Lu
Yan Ding
Xuelian He
机构：
[1] Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital,Precision Medical Center, Tongji Medical College
[2] Huazhong University of Science & Technology,Department of Pathology, Tongji Medical College
[3] Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital,Department of Respiratory Medicine, Tongji Medical College
[4] Huazhong University of Science & Technology,Department of Clinical Laboratory, Tongji Medical College
[5] Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital,Department of Rheumatology and Immunology, Tongji Medical College
[6] Huazhong University of Science & Technology,undefined
[7] Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital,undefined
[8] Huazhong University of Science & Technology,undefined
[9] Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital,undefined
[10] Huazhong University of Science & Technology,undefined
来源：
Pediatric Rheumatology | / 22卷
关键词：
Activated phosphoinositide 3-kinase δ syndrome; Immunodeficiency; Phenotype; ANCA-associated vasculitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] PIK3CD, IMMUNODEFICIENCY, MUTATIONS, GAIN-OF-FUNCTION
    Lara, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S146 - S146
  • [22] Deconvolution of bulk RNA sequencing in activated phosphoinositide 3-kinase δ syndrome
    Huang, Xia
    Gu, Haiyan
    CLINICAL RESPIRATORY JOURNAL, 2023, 17 (11): : 1190 - 1195
  • [23] Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase δ syndrome
    Rae, William
    Ramakrishnan, Kesava A.
    Gao, Yifang
    Ashton-Key, Margaret
    Pengelly, Reuben J.
    Patel, Sanjay V.
    Ennis, Sarah
    Williams, Anthony P.
    Faust, Saul N.
    CLINICAL IMMUNOLOGY, 2016, 171 : 38 - 40
  • [24] Phosphoinositide 3-kinase β, phosphoinositide 3-kinase δ, and phosphoinositide 3-kinase γ mediate the anti-inflammatory effects of magnesium sulfate
    Lee, Ping-Ying
    Yang, Chen-Hsien
    Kao, Ming-Chang
    Su, Nuan-Yen
    Tsai, Pei-Shan
    Huang, Chun-Jen
    JOURNAL OF SURGICAL RESEARCH, 2015, 197 (02) : 390 - 397
  • [25] Phosphoinositide 3-kinase
    Cantley, LC
    FASEB JOURNAL, 1998, 12 (08): : A1312 - A1312
  • [26] Transverse myelitis in a patient with activated phosphoinositide 3-kinase δ syndrome type 1
    Orf, Kate
    Abbas, Ahmed
    Abdel-Aziz, Khaled
    Burns, Siobhan O.
    CLINICAL IMMUNOLOGY, 2020, 219
  • [27] Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence
    Bloomfield, Marketa
    Klocperk, Adam
    Zachova, Radana
    Milota, Tomas
    Kanderova, Veronika
    Sediva, Anna
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [28] Activating PIK3CD mutations cause severe intestinal lymphonodular hyperplasia and an IBD-like phenotype
    Farachi, S.
    Werner, L.
    Konnikova, L.
    Rea, F.
    Vardi, I.
    Romeo, E.
    Barel, O.
    De Angelis, P.
    Dall'Oglio, L.
    Rechavi, G.
    Snapper, S.
    Somech, R.
    Weiss, B.
    Cancrini, C.
    Shouval, D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S36 - S37
  • [29] A child with hyper-IgM syndrome and multiple endocrinopathies with mutations in signal transducer and activator 5B (STAT5B), phosphatidylinositol 3-kinase catalytic subunit delta (PIK3CD) and phosphatidylinositol 3-kinase regulatory subunit 1 (PIK3R1)
    Curtiss, Miranda L.
    Descartes, Maria
    Korf, Bruce R.
    Atkinson, T. Prescott
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB172 - AB172
  • [30] Gain of Function Mutations of PIK3CD as a Cause of Primary Sclerosing Cholangitis
    Hartman, Heather N.
    Niemela, Julie
    Hintermeyer, Mary K.
    Garofalo, Mary
    Stoddard, Jennifer
    Verbsky, James W.
    Rosenzweig, Sergio D.
    Routes, John M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (01) : 11 - 14
12345